Neuropilin-1 in acute myeloid leukemia: Expression and role in proliferation and migration of leukemia cells

References

• He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 1997; 90: 739–751
   PubMed Web of Science ®Google Scholar
• Kolodkin A L, Levengood D V, Rowe E G, Tai Y T, Giger R J, Ginty D D. Neuropilin is a semaphorin III receptor. Cell 1997; 90: 753–762
   PubMed Web of Science ®Google Scholar
• Kawakami A, Kitsukawa T, Takagi S, Fujisawa H. Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J Neurobiol 1996; 29: 1–17
   PubMedGoogle Scholar
• Takahashi T, Fournier A, Nakamura F, Wang L H, Murakami Y, Kalb R G, et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 1999; 99: 59–69
   PubMed Web of Science ®Google Scholar
• Soker S, Takashima S, Miao H Q, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor. Cell 1998; 92: 735–745
   PubMed Web of Science ®Google Scholar
• Li M, Yang H, Chai H, Fisher W E, Wang X, Brunicardi F C, et al. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer 2004; 101: 2341–2350
   PubMed Web of Science ®Google Scholar
• Kawakami T, Tokunaga T, Hatanaka H, Kijima H, Yamazaki H, Abe Y, et al. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Cancer 2002; 95: 2196–2201
   PubMed Web of Science ®Google Scholar
• Hansel D E, Wilentz R E, Yeo C J, Schulick R D, Montgomery E, Maitra A. Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol 2004; 28: 347–356
   PubMed Web of Science ®Google Scholar
• Latil A, Bieche I, Pesche S, Valeri A, Fournier G, Cussenot O, et al. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int J Cancer 2000; 89: 167–171
   PubMed Web of Science ®Google Scholar
• Chen H, Chedotal A, He Z, Goodman C S, Tessier-Lavigne M. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphores Sema E and Sema IV but not Sema III. Neuron l997; 19: 547–559
   PubMed Web of Science ®Google Scholar
• Bachelder R E, Crago A, Chung J C, Wendt M A, Shaw L M, Robinson G, et al. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 2001; 61: 5736–5740
   PubMed Web of Science ®Google Scholar
• Schuch G, Machluf M, Bartsch G, Nomi M, Richard H, Atala A, et al. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood 2002; 100: 4622–4628
   PubMed Web of Science ®Google Scholar
• Kreuter M, Woelke K, Bieker R, Schliemann C, Steins M, Buechner T, et al. Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia 2006; 20: 1950–1954
   PubMed Web of Science ®Google Scholar
• Fiedler W, Graeven U, Ergun S, Verago S, Kilic N, Stockschlader M, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997; 89: 1870–1875
   PubMed Web of Science ®Google Scholar
• Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 2000; 106: 511–521
   PubMed Web of Science ®Google Scholar
• Santos S, Dias S. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways. Blood 2004; 103: 3883–3889
   PubMed Web of Science ®Google Scholar
• Parikh A A, Fan F, Liu W B, Ahmad S A, Stoeltzing O, Reinmuth N, et al. Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol 2004; 164: 2139–2151
   PubMed Web of Science ®Google Scholar
• Parikh A A, Liu W B, Fan F, Stoeltzing O, Reinmuth N, Bruns C J, et al. Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. Cancer 2003; 98: 720–729
   PubMed Web of Science ®Google Scholar
• Murga M, Fernandes-Capetillo O, Tosato G. Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood 2005; 105: 1992–1995
   PubMed Web of Science ®Google Scholar
• Gray M J, Wey J S, Belcheva A, McCarty M F, Trevino J G, Evans D B, et al. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Cancer Res 2005; 65: 3664–3670
   PubMed Web of Science ®Google Scholar
• Bachelder R E, Lipscomb E A, Lin X, Wendt M A, Chadborn N H, Eickholt B J, et al. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 2003; 63: 5230–5233
   PubMed Web of Science ®Google Scholar
• Miao H Q, Soker S, Feiner L, Alonso J L, Raper J A, Klagsbrun M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 1999; 146: 233–242
   PubMed Web of Science ®Google Scholar
• List A F. Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies. Oncologist 2001; 6(Suppl 1)24–31
   PubMed Web of Science ®Google Scholar
• Bellamy W T, Richter L, Sirjani D, Roxas C, Glinsmann-Gibson B, Frutiger Y, et al. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood 2001; 97: 1427–1434
   PubMed Web of Science ®Google Scholar
• Bonsi L, Pierdomenico L, Biscardi M, Marchionni C, Gavazzi S, Fossati V, et al. Constitutive and stimulated production of VEGF by human megakaryoblastic cell lines: effect on proliferation and signaling pathway. Int J Immunopathol Pharmacol 2005; 18: 445–455
   PubMed Web of Science ®Google Scholar
• Miao H Q, Lee P, Lin H, Soker S, Klagsbrun M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J 2000; 14: 2532–2539
   PubMed Web of Science ®Google Scholar
• Pan Q, Changthery Y, Liang W C, Stawicki S, Mak J, Rathore N, et al. Blocking Neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer cell 2007; 11: 53–67
   PubMed Web of Science ®Google Scholar